Related Experiment Video
Updated: Jul 3, 2026

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors
Published on: January 20, 2023
Medicinal chemistry of Hsp90 inhibitors
Martin J Drysdale1, Paul A Brough
1Vernalis R&D Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, UK. m.drysdale@vernalis.com
Abstract:
Heat shock protein (Hsp90) inhibitors are an increasingly interesting and important class of compounds where the first in class, natural product derived inhibitors such as 17-allylaminogeldanamycin (17-AAG), are entering late stage clinical development. Recently the emergence of synthetic, small molecule inhibitors has been described and both NVP-AUY922 and BIIB021 have entered clinical development. The medicinal chemistry of these and other published small molecule Hsp90 inhibitors is described in this review.

